Alto Neuroscience ANRO Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -38.9%+2.9pp | -41.8%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 20.5×+4.8× | 15.7×+0.3× | 15.4×-3.0× | 18.4×-4.1× | 22.5×+5.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0.1×-0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.1× | |
| Per Share | ||||||
| Book value per share | $7.40+41.2% | $5.24+27.3% | $4.12-9.7% | $4.56-11.4% | $5.14-16.5% | |
| Valuation | ||||||
| Market capitalization | $874.19M+1,358% | $552.98M+408% | $108.85M+60.8% | $67.68M+15.7% | $58.48M-48.7% | |
| Price / book | 3.6×+3.2× | 3.7×+2.7× | 1×+0.4× | 0.5×+0.1× | 0.4×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Alto Neuroscience's ratios come from?
- Every ratio is computed from Alto Neuroscience's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.